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ABSTRACT
Objective: The present study evaluated the subchronic toxicity of Lactobacillus paracasei mediated fermented Morinda citrifolia (Noni) juice (FMJ) 
using Sprague Dawley rat as a model system.
Methods: FMJ was prepared. The microbial load and pH of FMJ during fermentation were measured by a plating method and using pH meter, 
respectively. The healthy rats were supplemented with different doses of FMJ for 60 days. The changes in body weight of the animals were measured 
during FMJ intervention period. The blood and organs of the experimental rats were collected and were subjected to hematological and biochemical 
analysis by following standard hospital protocols, after the treatment period.
Results: After 30 days of fermentation, the pH of FMJ was reduced to 4.10 from 4.31. Lactobacillus load was increased gradually during fermentation 
while Bacillus spp. load decreased progressively, finally after 30 days of fermentation, no Bacillus spp., and yeast was found in FMJ. FMJ supplementation 
did not affect the body mass of experimental animals. The alternations in the organ weight were not associated with FMJ intervention. FMJ 
supplementation did not significantly affect the normal range of the selected hematological and biochemical parameters, which suggested that FMJ 
was not harmful to experimental rats.
Conclusion: FMJ was enriched with lactic acid bacteria, and free from pathogenic microbes. FMJ was found as safe for rodent consumption without 
any adverse effects. Further, studies are needed to explain the beneficial effect of L. paracasei mediated FMJ.
Keywords: Morinda citrifolia, Noni, Lactic acid bacteria, Subchronic Toxicity, Fermented plant juice.
INTRODUCTION
Fermentation is a process of breakdown of the complex molecule 
into simple sugars, and it has a history of thousands of years. The 
fermentation is extensively used in food industries to improve the 
quality of the foods and preserve the foods. Many peoples, especially 
Asians, strongly believe that the consumption of fermented foods cures 
the several health discomforts and it has also been proved [1]. The 
fermentation process enhanced the free-radical scavenging activity 
and polyphenolic content of Phyllanthus emblica fruit juice [2]. The 
naturally fermented traditional foods are the source of several beneficial 
microbes, for example, γ-aminobutyric acid, glutamate decarboxylase, 
and glutaminase producing microbes were reported [3,4]. The lactic acid 
bacteria mediated fermented Hericium erinaceus juice was reported as 
a health supplement to improve the health status of diabetes patent [5].
Morinda citrifolia L. (Noni) belongs to the family of Rubiaceae, and 
majorly found in Malaysia, Borneo, Indonesia, and Australia. Noni fruit 
has been used as medicine and food for thousands of years [6]. Noni fruit 
juice (NFJ) has been traditionally used to treat inflammation, diabetes, 
and noni is eaten raw [7]. The roots and barks of the noni plant have 
been used as dyes. The various part of M. citrifolia plants such as fruits, 
leaves, roots, and bark has been reported for several health benefits 
such as anticancer, anti-infection, anti-inflammation, pro-inflammatory 
effects, antitubercular, nephroprotective, and antidiabetes [7-16].
Approximately, more than 200 bioactive compounds from noni have 
been reported [17]. Even though noni and its products were reported 
for beneficial effects, some of the controversial reports also are 
there [18,19]. Some studies evaluated the subchronic toxicity of various 
part of noni plant extracts [20-24]. There was no literature on safety 
and subchronic toxicity of fermented noni fruits. The present study 
explained the subchronic toxicity of Lactobacillus paracasei HII03 
mediated fermented noni juice using a rat model system.
METHODS
Preparation of fermented M. citrifolia L. fruit juice (FMJ)
The water, M. citrifolia, and cane sugar were mixed in the ratio of 
10:3:1, and pasteurized. Then, the medium was inoculated with 10% 
of L. paracasei HII03 and fermented for 30 days at room temperature.
Evaluation of FMJ
The changes in color, odor, and consistency of FMJ were monitored by 
organoleptic techniques [2,25]. The pH of FMJ was kinetically assessed 
using pH meter (Inola, pH level 2, Weilheim) [2]. The samples were 
collected at different time points of fermentation, and the microbial load 
of FMJ was estimated by spread plate method using specific media [4].
Animals, intervention, and sample collection
All the animal (in vivo) experiments were permitted by the Ethical 
Committee of the Faculty of Medicine, Chiang Mai University (Approved 
protocol no: 1/2552 dated 23 June 2009). The rats (Sprague Dawley rats 
of 150–180 g in weight) needed for the experiments were purchased 
from National Laboratory Animal Center, Mahidol University, Thailand, 
and were randomly separated into four groups as follows:
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• Group 1: (Control): Typical laboratory food (commercial food no. 
C.P. 082, Perfect Companion Group Co., Ltd., Bangkok, Thailand) + 
water.
• Group 2: (Low dose or effective dose [ED]): Typical laboratory food 
+ water + 1.2 mL/kg/day of FMJ.
• Group 3: (High dose group; HD): Typical laboratory food + water + 
9.0 mL/kg/day of FMJ.
• Group 4: (Post-ED [PED]): Typical laboratory food + water + 
1.2 mL/kg/day of FMJ for 53 days (FMJ intervention was stopped 
before a week of animal sacrifice and testing).
The experimental rats were supplemented with FMJ for 60 days. After 
the intervention period, blood and internal organs were collected for 
the investigation.
Measurement of body mass, and valuation of hematological, and 
biochemical parameters
The body mass of rats during the experimental period was recorded 
using digital weighing balance. The changes in the weight were 
calculated as per the following formula.
Changes in body mass = final weight – the initial weight of rat.
The weight of the brain, eyes, heart, lung, liver, spleen, stomach, 
kidneys, and adrenal gland of the experimental rats was measured. 
Hemoglobin, hematocrits, white blood cell count, lymphocyte, 
platelets, and red blood cell count, aminotransaminase, alanine 
aminotransaminase, alkaline phosphatase levels, and triglyceride, 
and cholesterol level of the experimental rats were determined at MT 
InterMed (Hosptial) Growth Diags Co., Ltd. Ching Mai, Thailand, as per 
the standard procedures.
Statistical analysis
The experiments were performed in triplicate. The values were 
signified as a mean ± standard deviation. Duncan’s new multiple range 
tests determined the significant differences, at the 95% confidential 
level (p<0.05) by SPSS v.17 (Chicago, SPSS Inc, U.S.A).
RESULTS AND DISCUSSION
The noni fruit was fermented for 30 days, and the pH of the FMJ was 
decreased while the fermentation time increased. The initial pH of noni 
juice was 4.31, and the pH of fermented noni fruit was 4.10 (Fig. 1).
The specific bacterial fermentation facilitates the growth of starter 
culture. The microbial load of the FMJ has been increased gradually. 
The total bacterial count, and Lactobacillus spp. the content of FMJ was 
11.67, and 10.36 log CFU/mL, respectively. The microbial content was 
increased steadily without any decline until 30 days of fermentation. 
Bacillus spp. was observed in FMJ until 20 days of fermentation, but 
after 30 days, there were no live Bacillus cells detected. Yeast was not 
found in FMJ at any point of fermentation. The results suggested that 
the FMJ was rich in probiotic LAB strain and free from any harmful 
microbes; thus, FMJ was microbiologically safe (Fig. 2).
The average body mass of ED, HD, and PED group female rats after 
60 days of FMJ intervention was 17.85±16.94, 29.99±10.55, and 
23.57±7.56 g, respectively. Likely, the male rats of ED, HD, and PED 
groups exhibited the weight of 87.00±16.90, 97.86±20.68, and 
90.71±14.27 g, respectively. The weight changes were significantly 
compared to respective controls. Body weight of all of the experimental 
animals groups after the first 7 days of the test showed statistical 
significance when compared to the control group of both sexes. Males 
were statistically significant but were lowered, whereas females did not 
statistically show significant differences from day 21 of the experiment. 
The past day of the test, weight gain of both sexes did not show 
statistically significant differences from the control group (Table 1).
After 60 days of FMJ supplementation, experimental rats were euthanized, 
and the organs such as heart, brain, eyes, liver, lungs, spleen, kidney, stomach, 
and adrenal glands were collected, weighed. The changes in the organ 
weight have been represented in Table 2. There were no significant changes 
observed in any of the organs of FMJ supplemented rats. The changes in 
hematological and biochemical parameters during FMJ intervention have 
been reported (Table 3), and those changes were not significantly affected 
the normal range of the selected parameters, which suggested that the 
supplementation of FMJ was not harmful to experimental rats.
The effect of supplementation NFJ in the immune system of the host 
has been reported in mice. The intervention of low concentration of NFJ Fig. 1: The changes in the pH of fermented noni fruit juice
Fig. 2: Microbial load in noni fruit juice during fermentation
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reduced the intestinal expression of interleukin (IL-4) and IL-10 while 
high concentration increased the levels of IL-12, tumor necrosis factor 
(TNF-α), and interferon-gamma (IFN-γ) in the intestine. The increased 
level of IL-4, 10, 12, and 23, IFN-γ, and TNF-α was observed in the liver. The 
high concentration of NFJ caused mild edema in the intestine. The study 
suggested that the ingestion of a tested concentration of NFJ was safe [26].
Recently, Abu et al. reported the antitumor, subchronic toxicity, and 
immunoregulatory property of noni derived anthraquinone called, 
nordamnacanthal (ND). ND exhibited a cytotoxic effect on several breast 
cancer cells such as MCF-7, MDA-MB231, and 4T1. ND intervention 
does not cause any mortality and diminishes the development of 4T1 
in mice. The results suggested that ND supplementation enhanced the 
immunity without any adverse effects [24].
The aqueous extract of M. citrifolia leaves (AEM) was studied for its 
genotoxicity and subchronic toxicity in mice. The genotoxicity was 
measured by determining the incidence of micronuclei in mice bone 
marrow cells. The results suggested that about 2000 mg/kg of AEM 
was non-toxic in mice. The changes in hemoglobin and leukocyte count 
were observed while no significant changes were observed in the 
histological analysis [22]. Westendorf et al. [27] also reported that NFJ 
does not have genotoxicity, the toxic compound, anthraquinones, and 
not present in noni juice.
Table 1: The body mass of test animals during the experimental period
Day Body weight (g)
Male Female
Control ED* HD** PED*** Control ED HD PED
7 26.67±13.66 15.00±6.33### 18.57±4.57### 15.71±2.72### 7.50±1.14 9.28±1.38### 9.29±1.42## 9.26±4.56#
21 60.83±18.64 40.00±9.79# 46.43±10.38## 37.86±6.04## 23.33±6.58 10.71±5.76 18.57±8.93 20.00±12.15
30 88.33±20.74 56.43±10.56 65.71±19.98# 55.00±15.00 29.17±12.81 19.29±10.38 17.86±6.44 23.57±9.06
60 123.33±30.33 87.00±16.90 97.86±20.68 90.71±14.27 40.00±17.22 17.85±16.94 29.99±10.55 23.57±7.56
*ED: 1.2 mL kg/day, **HD: 9 mL/kg/day, ***PED: Post-effective dose (intervention has been stopped before 7 days of final assessments). #Significant difference (p<0.05) 
between control and test-group, ##significant difference (p<0.01) between control and test group, ###significant difference (p<0.001) between control and test group, 
HD: High-dose
Table 2: Changes in the organ weight after oral supplementation of FMJ
Organs Weight (g)
Male Female
ED* HD** PED*** ED HD PED
Brain −0.13±0.25 −0.07±0.07 −0.04±0.16 0.03±0.08 0±0.09 0.09±0.19
Eyes 0±0.02 −0.02±0.04 −0.01±0.03 −0.01±0.03 −0.04±0.06 −0.01±0.02
Heart 0.14±0.43 0.04±0.55 0.18±0.37 −0.12±0.29 0.01±0.26 −0.38±0.51
Lung −0.28±0.52 −0.13±0.36 −0.06±0.38 0.29±0.87 0.01±0.46 0.34±0.63
Liver −2.57±2.07 −0.4±2.2 −0.24±0.43 −3.76±0.91 −4.05±.25 −4.27±1.30
Spleen −0.22±0.30 −0.08±0.11 −0.08±0.05 −0.15±0.17 −0.03±0.06 −0.05±0.06
Stomach −0.05±0.19 0.22±0.22 0.25±0.16 0.29±0.18 0.27±0.20 0.15±0.45
Kidneys −0.21±0.53 −0.30±0.31 0.03±0.26 0.35±0.26 0.17±0.19 0.19±0.11
Adrenal Grand −0.01±0.02 −0.02±0.02 −0.01±0.04 0.03±0.02 0.01±0.01 0.02±0.02
The values were derived from the control values (the difference between control value and experimental value, after the experimental period) and were represented as 
a mean±standard deviation. *ED: 1.2 mL/kg/day, **HD: 9 mL/kg/day, ***PED: Post-effective dose, FMJ: Fermented M. citrifolia juice, HD: High-dose
Table 3: Effect of supplementation of FMJ on the hematological and biochemical parameters in hamster after 60 days of treatment
Parameters Male Female
ED HD PED ED HD PED
Hematological parameters
RBC (MµL) −0.78±0.26 −0.67±0.35 0.75±0.19 −0.22±0.20 −0.59±0.24 −0.20±0.14
WBC (MµL) −0.64±1.57 −3.50±2.94 1.78±1.79 −0.15±0.34 −0.16±0.12 −0.17±0.08
HGB (g/dL) 2.28±2.28 3.14±3.32 3.85±2.26 −9.60±4.01 −4.31±3.96 −4.88±2.02
Hematocrits (%) 1.92±1.99 0.78±3.45 0.50±2.16 −1.81±2.60 −2.10±3.43 −2.95±2.83
PMNC −1.92±1.99 −0.78±3.45 −0.50±2.16 1.81±2.60 2.10±3.43 2.957±2.83
Lymphocyte −0.66±0.99 0.23±1.56 −0.76±2.73 1.06±2.38 −0.27±2.45 −1.30±2.35
Platelets 0.37±0.25 0.26±0.34 0.34±0.19 0.47±0.23 0.85±0.35 0.45±0.32
Biochemical parameters
B.U.N. (mg/dL) −1.38±1.70 −4.10±6.20 −2.81±2.34 −3.90±4.89 −3.33±5.20 −3.76±4.12
Creatinine (mg/dL) −0.08±0.05 −0.18±0.24 −0.03±0.15 −0.01±0.19 0.03±0.20 −0.05±0.15
Cholesterol (mg/dL) −5.10±8.64 −7.81±14.94 −6.24±7.96 −13.25±14.57 −10.17±19.83 −15.7±19.79
TG (mg/dL) 11.04±12.93 17.90±16.86 4.19±4.04 −3.0±15.73 −4.0±17.78 −10.50±7.62
AST (IU/L) −37.43±52.52 −65.71±28.23 −36.00±28.48 −50.29±31.69 −34.33±34.05 −36.00±28.45
ALT (IU/L) −8.90±7.22 −10.90±15.19 −1.33±1.35 0.54±2.78 −7.46±1.42 −14.31±6.41
ALP (IU/L) −5.81±6.55 −13.81±11.28 −5.81±5.03 −6.04±4.64 6.10±5.30 −0.90±1.62
The values were derived from the control values (the difference between control value and experimental value, after the experimental period) and were represented  
as a mean±standard deviation, FMJ: Fermented juice. RBC: Red blood cells, WBC: White blood cells, HGB: Hemoglobin, PMNC: Polymorphonuclear cell, MµL: Million cells 
per microliter, B.U.N: Blood urea nitrogen, TG: Triglyceride, AST: Aspartate aminotransferase, ALT: Alanine aminotransferase, ALP: Alkaline phosphatase
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The dried noni fruit powder (2000 and 5000 mg/kg of body weight) was 
supplemented to rats along with normal laboratory feed for 13 weeks. 
The total protein content, spleen weight, and white blood cells count 
were significantly reduced in experimental rats. The hematological 
parameters were not affected significantly. The results suggested that 
even the high concentration of noni fruit powder (5000 mg/kg body 
weight/day) was non-toxic in Sprague-Dawley rats [21].
The ethanolic extract of M. citrifolia fruit (up to 5000 mg/kg) does 
not cause any toxic effects and mortality in rats. The biochemical, 
hematological, and histopathological parameters were not changed 
significantly. The study suggested that ethanolic extract of noni fruit was 
non-toxic [28]. Likely, several toxicity studies revealed that noni was not 
hepatotoxic, and it was not affected the embryo development [20,29,30].
CONCLUSION
The present study concluded that L. paracasei HII03 mediated 
FMJ was non-toxic to experimental rat and also revealed that LAB 
mediated fermented noni juice do not have any significant impact on 
hematological and biochemical parameters of the rat model. Further 
studies help to explore the pharmacological importance of FMJ.
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